These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 39232806)

  • 41. DNA methylation landscape of tumor-associated macrophages reveals pathways, transcription factors and prognostic value relevant to triple-negative breast cancer patients.
    Hey J; Halperin C; Hartmann M; Mayer S; Schönung M; Lipka DB; Scherz-Shouval R; Plass C
    Int J Cancer; 2023 Mar; 152(6):1226-1242. PubMed ID: 36408934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer.
    Kundu M; Butti R; Panda VK; Malhotra D; Das S; Mitra T; Kapse P; Gosavi SW; Kundu GC
    Mol Cancer; 2024 May; 23(1):92. PubMed ID: 38715072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of tumor‑associated macrophages with stromal and immune components in solid tumors: Research progress (Review).
    Kazakova A; Sudarskikh T; Kovalev O; Kzhyshkowska J; Larionova I
    Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36660926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review).
    Yu M; Yu H; Wang H; Xu X; Sun Z; Chen W; Yu M; Liu C; Jiang M; Zhang X
    Int J Oncol; 2024 Oct; 65(4):. PubMed ID: 39239752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.
    Bao X; Shi R; Zhao T; Wang Y; Anastasov N; Rosemann M; Fang W
    Cancer Immunol Immunother; 2021 Jan; 70(1):189-202. PubMed ID: 32681241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mouse 4T1 Breast Cancer Cell-Derived Exosomes Induce Proinflammatory Cytokine Production in Macrophages via miR-183.
    Guo J; Duan Z; Zhang C; Wang W; He H; Liu Y; Wu P; Wang S; Song M; Chen H; Chen C; Si Q; Xiang R; Luo Y
    J Immunol; 2020 Nov; 205(10):2916-2925. PubMed ID: 32989094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of tumor-associated macrophages in tumor immune evasion.
    Huang R; Kang T; Chen S
    J Cancer Res Clin Oncol; 2024 May; 150(5):238. PubMed ID: 38713256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spatial interaction and functional status of CD68
    Liu X; Zhang Z; Yuan J; Yu J; Chen D
    Front Immunol; 2024; 15():1396719. PubMed ID: 38799432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single-cell analyses reveal evolution mimicry during the specification of breast cancer subtype.
    Gao ZJ; Fang H; Sun S; Liu SQ; Fang Z; Liu Z; Li B; Wang P; Sun SR; Meng XY; Wu Q; Chen CS
    Theranostics; 2024; 14(8):3104-3126. PubMed ID: 38855191
    [No Abstract]   [Full Text] [Related]  

  • 50. Reprogramming of breast tumor-associated macrophages with modulation of arginine metabolism.
    Fernando V; Zheng X; Sharma V; Sweef O; Choi ES; Furuta S
    Life Sci Alliance; 2024 Nov; 7(11):. PubMed ID: 39191486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinct cuproptosis patterns in hepatocellular carcinoma patients correlate with unique immune microenvironment characteristics and cell-cell communication, contributing to varied overall survival outcomes.
    Wang Y; Mang X; Guo X; Pu J
    Front Immunol; 2024; 15():1379690. PubMed ID: 38868777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proliferating macrophages in human tumours show characteristics of monocytes responding to myelopoietic growth factors.
    Park SM; Chen CJ; Verdon DJ; Ooi MPY; Brooks AES; Martin RCW; Mathy JA; Emanuel PO; Dunbar PR
    Front Immunol; 2024; 15():1412076. PubMed ID: 38903497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of tumor-associated macrophage (TAM) differentiation by NDRG2 expression in breast cancer cells.
    Lee S; Lee A; Lim J; Lim JS
    BMB Rep; 2022 Feb; 55(2):81-86. PubMed ID: 34743782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TAMs in Brain Metastasis: Molecular Signatures in Mouse and Man.
    Schulz M; Sevenich L
    Front Immunol; 2021; 12():716504. PubMed ID: 34539650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unleashing nanotechnology to redefine tumor-associated macrophage dynamics and non-coding RNA crosstalk in breast cancer.
    Patni H; Chaudhary R; Kumar A
    Nanoscale; 2024 Oct; 16(39):18274-18294. PubMed ID: 39292162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comprehensive characterization of early-programmed tumor microenvironment by tumor-associated macrophages reveals galectin-1 as an immune modulatory target in breast cancer.
    Chung H; Gyu-Mi P; Na YR; Lee YS; Choi H; Seok SH
    Theranostics; 2024; 14(2):843-860. PubMed ID: 38169569
    [No Abstract]   [Full Text] [Related]  

  • 58. A Dynamic Transcriptome Map of Different Tissue Microenvironment Cells Identified During Gastric Cancer Development Using Single-Cell RNA Sequencing.
    Yin H; Guo R; Zhang H; Liu S; Gong Y; Yuan Y
    Front Immunol; 2021; 12():728169. PubMed ID: 34745098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor-associated macrophages: an effective player of the tumor microenvironment.
    Basak U; Sarkar T; Mukherjee S; Chakraborty S; Dutta A; Dutta S; Nayak D; Kaushik S; Das T; Sa G
    Front Immunol; 2023; 14():1295257. PubMed ID: 38035101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition.
    Rao R; Han R; Ogurek S; Xue C; Wu LM; Zhang L; Zhang L; Hu J; Phoenix TN; Waggoner SN; Lu QR
    Neuro Oncol; 2022 Apr; 24(4):584-597. PubMed ID: 34562087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.